These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1480063)
1. Primary structure and function of stromelysin/transin in cartilage matrix turnover. Wilhelm SM; Wunderlich D; Maniglia CA; Eisen AZ; Goldberg GI Matrix Suppl; 1992; 1():37-44. PubMed ID: 1480063 [TBL] [Abstract][Full Text] [Related]
2. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis. Xie DL; Hui F; Meyers R; Homandberg GA Arch Biochem Biophys; 1994 Jun; 311(2):205-12. PubMed ID: 8203882 [TBL] [Abstract][Full Text] [Related]
3. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Wilhelm SM; Collier IE; Kronberger A; Eisen AZ; Marmer BL; Grant GA; Bauer EA; Goldberg GI Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6725-9. PubMed ID: 3477804 [TBL] [Abstract][Full Text] [Related]
4. Identification of human intervertebral disc stromelysin and its involvement in matrix degradation. Liu J; Roughley PJ; Mort JS J Orthop Res; 1991 Jul; 9(4):568-75. PubMed ID: 1646316 [TBL] [Abstract][Full Text] [Related]
5. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Becker JW; Marcy AI; Rokosz LL; Axel MG; Burbaum JJ; Fitzgerald PM; Cameron PM; Esser CK; Hagmann WK; Hermes JD Protein Sci; 1995 Oct; 4(10):1966-76. PubMed ID: 8535233 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha and epidermal growth factor regulation of collagenase and stromelysin in adult porcine articular chondrocytes. Mitchell PG; Cheung HS J Cell Physiol; 1991 Oct; 149(1):132-40. PubMed ID: 1658009 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide activates metalloprotease enzymes in articular cartilage. Murrell GA; Jang D; Williams RJ Biochem Biophys Res Commun; 1995 Jan; 206(1):15-21. PubMed ID: 7529496 [TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and cartilage gene expression of equine stromelysin 1 (matrix metalloproteinase 3). Balkman CE; Nixon AJ Am J Vet Res; 1998 Jan; 59(1):30-6. PubMed ID: 9442239 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies against human collagenase and stromelysin. Su JL; Becherer JD; Edwards C; Bukhart W; McGeehan GM; Champion BR Hybridoma; 1995 Aug; 14(4):383-90. PubMed ID: 8522351 [TBL] [Abstract][Full Text] [Related]
10. Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins. Sanchez-Lopez R; Alexander CM; Behrendtsen O; Breathnach R; Werb Z J Biol Chem; 1993 Apr; 268(10):7238-47. PubMed ID: 8463259 [TBL] [Abstract][Full Text] [Related]
11. Purified staphylococcal culture medium stimulates neutral metalloprotease secretion from human articular cartilage. Williams RJ; Smith RL; Schurman DJ J Orthop Res; 1991 Mar; 9(2):258-65. PubMed ID: 1846914 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown. Cai L; Suboc P; Hogue DA; Fei DT; Filvaroff EH J Rheumatol; 2002 Aug; 29(8):1725-36. PubMed ID: 12180737 [TBL] [Abstract][Full Text] [Related]
13. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Yasuda T; Poole AR Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586 [TBL] [Abstract][Full Text] [Related]
14. Induction of metalloproteinase activity, cartilage matrix degradation and inhibition of endochondral mineralization in vitro by E. coli lipopolysaccharide is mediated by interleukin 1 alpha. Scheller M; Zimmermann B; Bernimoulin JP; Scholz P Cytokine; 1995 May; 7(4):331-7. PubMed ID: 8589263 [TBL] [Abstract][Full Text] [Related]
15. A matrix metalloproteinase proenzyme activator produced by articular cartilage. Towle CA; Wright M; Hecht AC; Kuong SJ; Papanicolas LE; Totkovic R; Mankin HJ; Treadwell BV Biochem Biophys Res Commun; 1998 Jun; 247(2):324-31. PubMed ID: 9642125 [TBL] [Abstract][Full Text] [Related]
16. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants. Todhunter RJ; Yeh LA; Sheldon A; Grisanzio L; Walker SL; Burton-Wurster N; Lust G Am J Vet Res; 1995 Sep; 56(9):1241-7. PubMed ID: 7486406 [TBL] [Abstract][Full Text] [Related]
17. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285 [TBL] [Abstract][Full Text] [Related]
18. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Homandberg GA; Hui F Arch Biochem Biophys; 1996 Oct; 334(2):325-31. PubMed ID: 8900407 [TBL] [Abstract][Full Text] [Related]
19. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Puente XS; Pendás AM; Llano E; Velasco G; López-Otín C Cancer Res; 1996 Mar; 56(5):944-9. PubMed ID: 8640782 [TBL] [Abstract][Full Text] [Related]
20. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs). Dittmann KH; Lottspeich F; Ries C; Petrides PE Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]